AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effects

 British pharma giant AstraZeneca has admitted that its Covid vaccine can cause rare side effects, The Telegraph (UK) has reported. Covishield can cause, in rare cases, a condition that leads to blood clots and low platelet count, the vaccine-maker has said in court documents. Covishield, developed by AstraZeneca and Oxford University during the pandemic, was produced by the Serum Institute of India and widely administered in the country.